Navigation Links
Emdeon Reports Third Quarter 2011 Results
Date:11/9/2011

-

129,175

-

-

129,175Dental-

23,464

-

-

23,464-

23,808

-

-

23,808Pharmacy services-

-

63,052

-

63,052-

-

59,830

-

59,830Inter-segment revenue 2,572

391

-

(2,963)

-2,311

241

-

(2,552)

-Net revenue 342,763

432,906

63,052

(2,963)

835,758317,774

351,438

59,830

(2,552)

726,490Costs and expenses:Cost of operations 230,851

264,396

26,444

(2,774)

518,917207,455

216,561

21,790

(2,457)

443,349Development and engineering 8,804

13,737

5,249

-

27,7908,779

11,766

5,300

-

25,845Sales, marketing, general and administrative 20,857

27,766

4,126

45,231

97,98019,742

21,326

4,520

35,268

80,856Segment contribution (1)$
82,251

$
27,007

$
27,233

$
(45,420)

191,071$
81,798

$
,785

$
28,220

$
(35,363)

176,440Depreciation and amortization 116,78687,054Interest income (10)(12)Interest expense 37,85847,747Other(8,036)(4,140)Income before income tax provision $
44,473$
45,791(1) Segment contribution has been reduced by equity-based compensation expense of $6,126, $4,844, $17,610 and $12,691 for the three months and nine months ended September 30, 2011 and 2010, respectively. Segment contribution without such equity-based compensation expense would have been $69,005, $62,759, $208,681 and $189,131 for the three and nine months ended September 30, 2011 and 2010, respectively.Explanation of Non-GAAP Financial MeasuresEmdeon's management believes
'/>"/>

SOURCE Emdeon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Emdeon to Present at the Piper Jaffray Annual Health Care Conference
2. Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality
3. Emdeon Recommends Secure Interim Solutions to Avert Delays in the Implementation of ePrescribing of Controlled Substances
4. Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity
5. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 According to ... & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), ... QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global ... Oligonucleotide Synthesis Market is expected to reach $1,712.1 ... growing at a CAGR of 9.8% from 2014 ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... VANCOUVER, British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" ... 2014 fiscal year-end financial statements.  The Company recently changed ... to facilitate an application to list its common stock ... possible. DelMar,s financial statements as filed with ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
(Date:9/1/2014)... More than 200 Lipitor lawsuit ( http://www.thelipitorlawsuit.com/ ... that continues to progress in the U.S. District Court, ... , A federal Case List published on August 15th ... medication by plaintiffs who developed Type 2 diabetes allegedly ... failed to adequately warn patients and their doctors about ...
(Date:9/1/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... American aid workers successfully cured a group of monkeys infected ... The drug, ZMapp, prompted recovery in all 18 monkeys who ... five days after infection. ZMapp even cured monkeys with ... away from death, said study senior author Gary Kobinger, chief ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 As well ... training, Derek is currently pursuing counselor certification in Louisiana. ... advance through the CPI training program as well as ... I have grown both personally and professionally. I ... I am competently able to do so. As ...
(Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
(Date:9/1/2014)... Secaucus, NJ (PRWEB) September 01, 2014 Registration ... For The Warriors® 5K and 1-Mile Race to be held ... at The Plaza Court Yard at Harmon Meadow in Secaucus, ... For The Warriors®, a national nonprofit dedicated to restoring a ... for our service members and our military families. , General ...
Breaking Medicine News(10 mins):Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2
... For the first time, universal standards to guide ... labels to reflect how patients read and understand medication ... labels can vary significantly from pharmacy to pharmacy, even ... the safe use of medications. The new standards, developed ...
... hills . . . They might get a pedestrian ... someone in an electric wheelchair, they could mean terrain ... To address this problem, researchers at the Florida A&M ... technology that will enable electric-powered wheelchairs to detect hazardous ...
... into a collaborative agreement with Veridex LLC to establish ... cell (CTC) technologies. The overall goal of the agreement ... and characterizing CTCs, solid tumor cells found at extremely ... key to noninvasive characterization of cancer and potentially to ...
... and other developing countries is seasonal, linked to farm ... according to an international team of researchers from Uganda ... approach to this problem is prevention. "Hydrocephalus in infants ... Steven Schiff, the Brush Chair professor of engineering and ...
... a clear association of tuberculosis with lung cancer remains ... January issue of the Journal of Thoracic Oncology ... among people with tuberculosis. Researchers at China Medical ... patients covered under the country,s National Health Insurance (NHI) ...
... Dec. 31 (HealthDay News) -- Two to three times more ... and New Year,s than over comparable periods of time during ... on Alcohol Abuse and Alcoholism. The agency also noted ... an impaired driver, compared to 28 percent for the rest ...
Cached Medicine News:Health News:Universal standards proposed for prescription container labels to help reduce medication misuse 2Health News:Universal standards proposed for prescription container labels to help reduce medication misuse 3Health News:FSU researchers helping electric-wheelchair users move more easily 2Health News:FSU researchers helping electric-wheelchair users move more easily 3Health News:Mass. General enters collaboration to develop new approach to capturing circulating tumor cells 2Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 2Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 3Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 4Health News:Study finds evidence of increased lung cancer risk among tuberculosis patients 2Health News:Holiday Drinking Raises Death Toll on U.S. Roads, Experts Warn 2
... stereopsis from 800 to 40 ... young as 2 years of ... from left to right., ,Randot ... Book #1: 200 & 100 ...
... The Standard for Stereo Depth Perception. ... 1200 sec or arc) and Fine ... Circle Test (800 to 40 sec ... (400 to 100 sec of arc), ...
The Emit Phenytoin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of phenytoin in human serum or plasma....
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of phenytoin in human serum or plasma. Kits are conveniently packaged in Olympus Reagent Cartrid...
Medicine Products: